BASF signs agreement to acquire Cognis for equity purchase price of euro 700 million

NewsGuard 100/100 Score

BASF SE has reached an agreement with Cognis Holding Luxembourg S.a r.l. controlled by Permira Funds, GS Capital Partners and SV Life Sciences to acquire the specialty chemicals company Cognis for an equity purchase price of euro 700 million. Including net financial debt and pension obligations, the enterprise value of the transaction is euro 3.1 billion. The acquisition is subject to clearance by the competent merger control authorities. Closing of the transaction is expected for November 2010 at the latest.

"With the acquisition of Cognis, we are strengthening our portfolio with cyclically robust and profitable businesses and further expanding our position as the world's leading chemical company," said Dr. Jurgen Hambrecht, Chairman of the Board of Executive Directors of BASF SE.

Cognis is a worldwide supplier of innovative solutions and products based on renewable raw materials for the health and nutrition market, as well as the cosmetics, detergents and cleaners industries. Another main focus is on products for a number of other industries, such as mining, lubricants, coatings, as well as agriculture. The company employs about 5,500 people, and it operates production sites and service centers in 30 countries. In 2009, Cognis had sales of about euro 2.6 billion and an EBITDA (earnings before interest, taxes, depreciation and amortization) of euro 322 million.

"With the support of our owners Permira Funds and CS Capital Partners, we have become a leading innovative supplier of specialty chemicals," stated Dr. Antonio Trius, Chief Executive Officer of Cognis. "In particular, our focus on wellness and sustainability and our expertise in renewable raw-material based products have been our main success factors. We are convinced that there are excellent opportunities through combining the strengths of Cognis and BASF."

The customers of Cognis include global consumer goods companies as well as regional suppliers from the personal and home care industries, and from the area of health and nutrition. The company also offers products for coatings and paints, lubricants for the transport industries and additives for chemical-technical applications for agriculture and mining.

Growth – Value – Sustainability

"With this acquisition, we want to achieve a leading position in personal care ingredients, strengthen our leading position in value added products for home care and establish a strong position in health and nutrition products," said Dr. John Feldmann, member of the Board of Executive Directors of BASF and responsible for the Performance Products segment. "By purchasing Cognis, we will, in particular, expand our portfolio with products based on renewable raw materials. A broader and more attractive offering of products and services combined with our research and development expertise will allow us to become an even more important partner for joint development projects with our customers. This will contribute to making them even more successful."

Following the necessary approvals, the business will be integrated into BASF's Performance Products segment. The segment had sales of euro 9.4 billion in 2009. Performance products help customers to improve their products and processes. They give special characteristics to countless everyday products: for example diapers, paper, vitamins for food supplements, UV filters for sunscreen, plastic additives and products for water treatment, mining applications and for the oil, automotive and coatings industries. "The acquisition of Cognis is an important step in our segment strategy of Growth, Value and Sustainability," explained Feldmann.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Meals provided in early education and childcare centers do not meet national dietary recommendations